| Chimeric antigen receptor T cells for sustained remissions in leukemia SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ... New England Journal of Medicine 371 (16), 1507-1517, 2014 | 6137 | 2014 |
| Chimeric antigen receptor–modified T cells for acute lymphoid leukemia SA Grupp, M Kalos, D Barrett, R Aplenc, DL Porter, SR Rheingold, ... New England Journal of Medicine 368 (16), 1509-1518, 2013 | 4291 | 2013 |
| Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo MC Milone, JD Fish, C Carpenito, RG Carroll, GK Binder, D Teachey, ... Molecular therapy 17 (8), 1453-1464, 2009 | 1476 | 2009 |
| Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia DT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ... Cancer discovery 6 (6), 664-679, 2016 | 1095 | 2016 |
| Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ... Cancer cell 22 (2), 153-166, 2012 | 884 | 2012 |
| Managing cytokine release syndrome associated with novel T cell-engaging therapies SL Maude, D Barrett, DT Teachey, SA Grupp The Cancer Journal 20 (2), 119-122, 2014 | 878 | 2014 |
| CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia SL Maude, DT Teachey, DL Porter, SA Grupp Blood, The Journal of the American Society of Hematology 125 (26), 4017-4023, 2015 | 869 | 2015 |
| Gene therapy in patients with transfusion-dependent β-thalassemia AA Thompson, MC Walters, J Kwiatkowski, JEJ Rasko, JA Ribeil, ... New England Journal of Medicine 378 (16), 1479-1493, 2018 | 772 | 2018 |
| Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy DT Teachey, SR Rheingold, SL Maude, G Zugmaier, DM Barrett, AE Seif, ... Blood, The Journal of the American Society of Hematology 121 (26), 5154-5157, 2013 | 704 | 2013 |
| Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop JB Oliveira, JJ Bleesing, U Dianzani, TA Fleisher, ES Jaffe, MJ Lenardo, ... Blood, The Journal of the American Society of Hematology 116 (14), e35-e40, 2010 | 563 | 2010 |
| Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia JC Fitzgerald, SL Weiss, SL Maude, DM Barrett, SF Lacey, JJ Melenhorst, ... Critical care medicine 45 (2), e124-e131, 2017 | 484 | 2017 |
| Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2 C Diorio, SE Henrickson, LA Vella, KO McNerney, J Chase, ... The Journal of clinical investigation 130 (11), 5967-5975, 2020 | 452 | 2020 |
| Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia SL Maude, SK Tasian, T Vincent, JW Hall, C Sheen, KG Roberts, AE Seif, ... Blood, The Journal of the American Society of Hematology 120 (17), 3510-3518, 2012 | 370 | 2012 |
| T-cell acute lymphoblastic leukemia EA Raetz, DT Teachey Hematology 2014, the American Society of Hematology Education Program Book …, 2016 | 333 | 2016 |
| Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome C Kotch, D Barrett, DT Teachey Expert review of clinical immunology 15 (8), 813-822, 2019 | 324 | 2019 |
| Treatment of E pstein B arr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens DB Chellapandian, R Das, K Zelley, SJ Wiener, H Zhao, DT Teachey, ... British journal of haematology 162 (3), 376-382, 2013 | 302 | 2013 |
| Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia DT Teachey, CH Pui The Lancet Oncology 20 (3), e142-e154, 2019 | 298 | 2019 |
| Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia SL Maude, S Dolai, C Delgado-Martin, T Vincent, A Robbins, ... Blood, The Journal of the American Society of Hematology 125 (11), 1759-1767, 2015 | 267 | 2015 |
| Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events MV Maus, S Alexander, MR Bishop, JN Brudno, C Callahan, ML Davila, ... Journal for immunotherapy of cancer 8 (2), e001511, 2020 | 246 | 2020 |
| Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial KL Bride, T Vincent, K Smith-Whitley, MP Lambert, JJ Bleesing, AE Seif, ... Blood, The Journal of the American Society of Hematology 127 (1), 17-28, 2016 | 229 | 2016 |
